HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Arroyave, C. M. Articles by Müller-Eberhard, H. J. Search for Related Content PubMed Articles by Arroyave, C. M. Articles by Müller-Eberhard, H. J.

Interactions between Human C5, C6, and C7 and Their Functional Significance in Complement-Dependent Cytolysis^1,2,

From the Department of Experimental Pathology, Scripps Clinic and Research Foundation, La Jolla, California 92037

Abstract

Two types of complexes were observed between C5, C6 and C7. In their native form these three complement proteins enter into reversible interactions which were demonstrated by zone ultracentrifugation. Interactions between C5 and C6 occurred in absence of C7 and between C5 and C7 in absence of C6. Presence of C6, however, enhanced the association of C5 and C7.

Formation of a stable C5–C6 complex was effected by the complement enzyme
. This complex (
) had a sedimentation coefficient of 12 to 14S and exhibited the ability to attach itself firmly to non-sensitized sheep erythrocytes (E) in presence of C7.

activity was also generated by trypsin or plasmin, suggesting the existence of a new pathway of complement activation by non-complement enzymes beginning with C5.
produced with trypsin or
displayed typical ultrastructural membrane lesions and was susceptible to lysis by C8 and C9.

Regardless of experimental conditions, C5, C6, and C7 were taken up by the surface of cells in equimolar quantities. The affinity between native C5, C6, and C7 displayed in free solution, and the equimolarity of the cell-bound equivalents, support the concept of a firm trimolecular assembly as the topologic base of the membrane attack mechanism of complement.

Footnotes

¹ This is publication number 679 from the Department of Experimental Pathology, Scripps Clinic and Research Foundation, La Jolla, California 92037.

² This work was supported by United States Public Health Service Grant AI-07007.

This article has been cited by other articles:

				C.-T. Thai and R. T. Ogata Recombinant C345C and Factor I Modules of Complement Components C5 and C7 Inhibit C7 Incorporation into the Complement Membrane Attack Complex J. Immunol., May 15, 2005; 174(10): 6227 - 6232. [Abstract] [Full Text] [PDF]

				C.-T. Thai and R. T. Ogata Complement Components C5 and C7: Recombinant Factor I Modules of C7 Bind to the C345C Domain of C5 J. Immunol., October 1, 2004; 173(7): 4547 - 4552. [Abstract] [Full Text] [PDF]

				C.-T. Thai and R. T. Ogata Expression and Characterization of the C345C/NTR Domains of Complement Components C3 and C5 J. Immunol., December 15, 2003; 171(12): 6565 - 6573. [Abstract] [Full Text] [PDF]

				R. G. DiScipio, S. M. Linton, and N. K. Rushmere Function of the Factor I Modules (FIMS) of Human Complement Component C6 J. Biol. Chem., November 5, 1999; 274(45): 31811 - 31818. [Abstract] [Full Text] [PDF]

				V. J. Christiansen, P. J. Sims, and K. K. Hamilton Complement C5b-9 Increases Plasminogen Binding and Activation on Human Endothelial Cells Arterioscler. Thromb. Vasc. Biol., January 1, 1997; 17(1): 164 - 171. [Abstract] [Full Text]